Clinical Trials · NCT02506023
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Emory University
- Enrollment
- 2
- Start date
- Jul 2015
- Locations
- 2 sites, United States
- Primary endpoint
- Percentage of subjects that achieve and sustain >50% increase in Factor VIII antigen levels